Please use a minimum of three unique search words
Our search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Trulicity ® (dulaglutide)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Trulicity® (dulaglutide): Needle Information
The dulaglutide pen comes with a permanently attached needle. The needle is not removable.
UK_cFAQ_GLP5056_NEEDLE_INFORMATION_VIDEO_LINK_INC
en-GB
What are the specifications of the needle on a dulaglutide pen?
The dulaglutide prefilled pen is manufactured with a 29 G (0.33 mm) x ½’’ (12.7 mm) needle. All dulaglutide prefilled pens have the same needle size.1
The needle is permanently attached to the pen and cannot be taken off.
- Therefore, it is not possible to attach spare needles or safety needles.1
The injection depth of the needle is approximately 5 mm.1
The needle is lubricated.1
How can the user avoid damaging the needle?
Make sure the pen is locked.
Pull off the grey base cap.
Do not put the base cap back on – this could damage the needle.
- Discard the base-cap.
Do not touch the needle.2
Please find below a link to a short video that demonstrates how the user can avoid damaging the needle.
References
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2Trulicity [instructions for use]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 21 January 2022
Contact Lilly
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com
Available Mon - Fri, 10am - 4pm, excluding Bank Holidays